These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Lilly Tino faces backlash after posting a Disney bathroom selfie with women and children visible, sparking privacy concerns ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

A Chinese company that developed the country’s first indigenous therapy for Alzheimer’s disease has suspended production and sales of the drug, casting doubts on the treatment’s future.

Stock futures held steady early Tuesday as investors remained cautious ahead of key inflation data amid closely watched ...

Medical innovations in healthcare today move beyond disease treatment to revolutionize treatment delivery methods. The injectable drug delivery devices market leads healthcare delivery transformation ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

Pfizer's stock experienced a 2.66% increase on June 9, 2025, closing at $23.97, marking its second consecutive day of gains.

Eli Lilly lands an $870 million pact with Camurus to build long-acting obesity treatments, tapping FluidCrystalslow-release ...

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would ...